{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:56:44Z","timestamp":1791845804183,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["82474275"],"award-info":[{"award-number":["82474275"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-NHLHCRF-LX-02-02"],"award-info":[{"award-number":["2022-NHLHCRF-LX-02-02"]}]},{"name":"Excellence & Innovation Initiative of China-Japan Friendship Hospital","award":["ZRZC2025-ZYC02"],"award-info":[{"award-number":["ZRZC2025-ZYC02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Rheumatoid arthritis (RA) is a complex and highly disabling chronic autoimmune disease. As the disease progresses, patients often develop complications such as joint destruction and cardiovascular diseases, posing significant threats to human health. Celastrol, a major bioactive compound extracted from the traditional Chinese herb Tripterygium wilfordii Hook. f., exhibits potent immunomodulatory and anti-inflammatory properties. However, the specific mechanisms underlying its protective effects against bone destruction in RA remain poorly understood. To elucidate its potential therapeutic mechanisms, this study retrieved three gene expression datasets\u2014GSE55235, GSE93777, and GSE200815\u2014from the Gene Expression Omnibus (GEO) database. The primary molecular targets of celastrol were obtained from the HERB and TCMSP platforms. Functional mechanisms associated with these targets were explored using gene set variation analysis (GSVA) and weighted gene co-expression network analysis (WGCNA). Furthermore, molecular docking, immune infiltration analysis, and single-cell RNA sequencing analysis were employed to investigate the role of key target genes. In this study, thirteen potential target genes of celastrol in RA have been identified, including\n                    <jats:italic>ADAMTS5<\/jats:italic>\n                    ,\n                    <jats:italic>AGTR1<\/jats:italic>\n                    ,\n                    <jats:italic>ALOX5<\/jats:italic>\n                    ,\n                    <jats:italic>CTSB<\/jats:italic>\n                    ,\n                    <jats:italic>MMP3<\/jats:italic>\n                    ,\n                    <jats:italic>MMP9<\/jats:italic>\n                    ,\n                    <jats:italic>MYC<\/jats:italic>\n                    ,\n                    <jats:italic>TNF<\/jats:italic>\n                    ,\n                    <jats:italic>ITGA4<\/jats:italic>\n                    ,\n                    <jats:italic>ITGB7<\/jats:italic>\n                    ,\n                    <jats:italic>MMP1<\/jats:italic>\n                    ,\n                    <jats:italic>MMP13<\/jats:italic>\n                    , and\n                    <jats:italic>PPARG<\/jats:italic>\n                    . Among these,\n                    <jats:italic>ALOX5<\/jats:italic>\n                    was found to significantly promote MMP3 protein expression, based on which a regulatory model with high predictive power was constructed. GSVA analysis revealed that the TNF-NF\u03baB pathway was significantly activated in RA and exhibited a strong positive correlation with\n                    <jats:italic>ALOX5<\/jats:italic>\n                    expression. Further experimental analysis demonstrated that knockdown of\n                    <jats:italic>ALOX5<\/jats:italic>\n                    and its shared transcription factor with\n                    <jats:italic>MMP2<\/jats:italic>\n                    resulted in a significant downregulation of both genes and inhibition of TNF-NF\u03baB pathway activity. Single-cell transcriptomic analysis showed that\n                    <jats:italic>ALOX5<\/jats:italic>\n                    was predominantly expressed in macrophages, and the AddModuleScore of celastrol-targeted genes in this cell type was significantly higher than in other cell types, suggesting that macrophages may serve as key effector cells in celastrol-mediated treatment of RA. Celastrol might attenuate RA bone destruction by inhibiting the expression of the\n                    <jats:italic>ALOX5<\/jats:italic>\n                    gene in macrophages, thereby suppressing the activation of the NF-\u03baB pathway and subsequently reducing the production of matrix metalloproteinases.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-33001-x","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T19:53:01Z","timestamp":1766001181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Celastrol suppresses bone destruction in rheumatoid arthritis by inhibiting ALOX5 expression in macrophages via the NF-\u03baB pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"YiQing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YanYu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoJing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LongXiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhiKun","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwen","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"issue":"1","key":"33001_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jaut.2009.12.009","volume":"35","author":"GJ Tob\u00f3n","year":"2010","unstructured":"Tob\u00f3n, G. J., Youinou, P. & Saraux, A. The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. J. Autoimmun. 35 (1), 10\u201314. https:\/\/doi.org\/10.1016\/j.jaut.2009.12.009 (2010).","journal-title":"J. Autoimmun."},{"issue":"2","key":"33001_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","volume":"46","author":"G Firestein","year":"2017","unstructured":"Firestein, G. & McInnes, I. B. Immunopathogenesis of rheumatoid arthritis. Immunity 46 (2), 183\u2013196. https:\/\/doi.org\/10.1016\/j.immuni.2017.02.006 (2017).","journal-title":"Immunity"},{"issue":"5","key":"33001_CR3","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00296-020-04731-0","volume":"41","author":"K Almutairi","year":"2021","unstructured":"Almutairi, K., Nossent, J., Preen, D., Keen, H. & Inderjeeth, C. The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol. Int. 41 (5), 863\u2013877. https:\/\/doi.org\/10.1007\/s00296-020-04731-0 (2021).","journal-title":"Rheumatol. Int."},{"key":"33001_CR4","doi-asserted-by":"publisher","first-page":"109130","DOI":"10.1016\/j.intimp.2022.109130","volume":"111","author":"M Aliyu","year":"2022","unstructured":"Aliyu, M. et al. Interleukin-6 cytokine: an overview of the immune regulation, immune dysregulation, and therapeutic approach. Int. Immunopharmacol. 111, 109130. https:\/\/doi.org\/10.1016\/j.intimp.2022.109130 (2022).","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"33001_CR5","doi-asserted-by":"publisher","first-page":"102741","DOI":"10.1016\/j.autrev.2020.102741","volume":"20","author":"DD Ilchovska","year":"2021","unstructured":"Ilchovska, D. D. & Barrow, D. M. An overview of the NF-kB mechanism of pathophysiology in rheumatoid arthritis, investigation of the NF-kB ligand RANKL and related nutritional interventions. Autoimmun. Rev. 20 (2), 102741. https:\/\/doi.org\/10.1016\/j.autrev.2020.102741 (2021).","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"33001_CR6","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2353\/ajpath.2006.051161","volume":"169","author":"J Wang","year":"2006","unstructured":"Wang, J. et al. JAB1 determines the response of rheumatoid arthritis synovial fibroblasts to tumor necrosis Factor-\u03b1. Am. J. Pathol. 169 (3), 889\u2013902. https:\/\/doi.org\/10.2353\/ajpath.2006.051161 (2006).","journal-title":"Am. J. Pathol."},{"issue":"6","key":"33001_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/1744666X.2017.1295850","volume":"13","author":"M Narazaki","year":"2017","unstructured":"Narazaki, M., Tanaka, T. & Kishimoto, T. The role and therapeutic targeting of IL-6 in rheumatoid arthritis. Expert Rev. Clin. Immunol. 13 (6), 535\u2013551. https:\/\/doi.org\/10.1080\/1744666X.2017.1295850 (2017).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"33001_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","volume":"15","author":"M Locati","year":"2020","unstructured":"Locati, M., Curtale, G. & Mantovani, A. Diversity, mechanisms, and significance of macrophage plasticity. Annu. Rev. Pathol. 15, 123\u2013147. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-012418-012718 (2020).","journal-title":"Annu. Rev. Pathol."},{"key":"33001_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2018.05.009","volume":"128","author":"A Mohammadi","year":"2018","unstructured":"Mohammadi, A., Sharifi, A., Pourpaknia, R., Mohammadian, S. & Sahebkar, A. Manipulating macrophage polarization and function using classical HDAC inhibitors: implications for autoimmunity and inflammation. Crit. Rev. Oncol. Hematol. 128, 1\u201318. https:\/\/doi.org\/10.1016\/j.critrevonc.2018.05.009 (2018).","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"33001_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/ijms23010144","volume":"23","author":"S Kadomoto","year":"2021","unstructured":"Kadomoto, S., Izumi, K. & Mizokami, A. Macrophage polarity and disease control. Int. J. Mol. Sci. 23 (1), 144. https:\/\/doi.org\/10.3390\/ijms23010144 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"33001_CR11","doi-asserted-by":"publisher","first-page":"105091","DOI":"10.1016\/j.jbspin.2020.105091","volume":"88","author":"N Hannemann","year":"2021","unstructured":"Hannemann, N., Apparailly, F. & Courties, G. New insights into macrophage heterogeneity in rheumatoid arthritis. Jt. Bone Spine. 88 (1), 105091. https:\/\/doi.org\/10.1016\/j.jbspin.2020.105091 (2021).","journal-title":"Jt. Bone Spine"},{"key":"33001_CR12","doi-asserted-by":"publisher","first-page":"763832","DOI":"10.3389\/fimmu.2021.763832","volume":"12","author":"B Grillet","year":"2021","unstructured":"Grillet, B. et al. Proteoform analysis of matrix Metalloproteinase-9\/Gelatinase B and discovery of its citrullination in rheumatoid arthritis synovial fluids. Front. Immunol. 12, 763832. https:\/\/doi.org\/10.3389\/fimmu.2021.763832 (2021).","journal-title":"Front. Immunol."},{"issue":"5","key":"33001_CR13","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3899\/jrheum.200265","volume":"48","author":"G Ozen","year":"2021","unstructured":"Ozen, G., Pedro, S. & Michaud, K. The risk of cardiovascular events associated with disease-modifying antirheumatic drugs in rheumatoid arthritis. J. Rheumatol. 48 (5), 648\u2013655. https:\/\/doi.org\/10.3899\/jrheum.200265 (2021).","journal-title":"J. Rheumatol."},{"issue":"9602","key":"33001_CR14","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60784-3","volume":"370","author":"JS Smolen","year":"2007","unstructured":"Smolen, J. S., Aletaha, D., Koeller, M., Weisman, M. H. & Emery, P. New therapies for treatment of rheumatoid arthritis. Lancet 370 (9602), 1861\u20131874. https:\/\/doi.org\/10.1016\/S0140-6736(07)60784-3 (2007).","journal-title":"Lancet"},{"issue":"2","key":"33001_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrrheum.2013.168","volume":"10","author":"GR Burmester","year":"2014","unstructured":"Burmester, G. R., Feist, E. & D\u00f6rner, T. Emerging cell and cytokine targets in rheumatoid arthritis. Nat. Rev. Rheumatol. 10 (2), 77\u201388. https:\/\/doi.org\/10.1038\/nrrheum.2013.168 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"11","key":"33001_CR16","doi-asserted-by":"publisher","first-page":"e698","DOI":"10.1016\/S2665-9913(20)30276-9","volume":"2","author":"JCE Lane","year":"2020","unstructured":"Lane, J. C. E. et al. Risk of hydroxychloroquine alone and in combination with Azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. Lancet Rheumatol. 2 (11), e698\u2013e711. https:\/\/doi.org\/10.1016\/S2665-9913(20)30276-9 (2020).","journal-title":"Lancet Rheumatol."},{"key":"33001_CR17","doi-asserted-by":"publisher","first-page":"106527","DOI":"10.1016\/j.intimp.2020.106527","volume":"84","author":"Q Gao","year":"2020","unstructured":"Gao, Q., Qin, H., Zhu, L., Li, D. & Hao, X. Celastrol attenuates collagen-induced arthritis via inhibiting oxidative stress in rats. Int. Immunopharmacol. 84, 106527. https:\/\/doi.org\/10.1016\/j.intimp.2020.106527 (2020).","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"33001_CR18","doi-asserted-by":"publisher","first-page":"7728","DOI":"10.1021\/acs.nanolett.0c03279","volume":"20","author":"L An","year":"2020","unstructured":"An, L. et al. Inflammation-targeted celastrol nanodrug attenuates collagen-induced arthritis through NF-\u03baB and Notch1 pathways. Nano Lett. 20 (10), 7728\u20137736. https:\/\/doi.org\/10.1021\/acs.nanolett.0c03279 (2020).","journal-title":"Nano Lett."},{"issue":"1","key":"33001_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"33001_CR20","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"33001_CR21","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. Publ. Protein Soc. 28 (11), 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci. Publ. Protein Soc."},{"issue":"D1","key":"33001_CR22","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44 (D1), D457\u2013462. https:\/\/doi.org\/10.1093\/nar\/gkv1070 (2016).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"33001_CR23","doi-asserted-by":"publisher","first-page":"D964","DOI":"10.1093\/nar\/gkac1066","volume":"51","author":"S Guo","year":"2023","unstructured":"Guo, S. et al. GPSAdb: a comprehensive web resource for interactive exploration of genetic perturbation RNA-seq datasets. Nucleic Acids Res. 51 (D1), D964\u2013D968. https:\/\/doi.org\/10.1093\/nar\/gkac1066 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"33001_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods. 12 (5), 453\u2013457. https:\/\/doi.org\/10.1038\/nmeth.3337 (2015).","journal-title":"Nat. Methods"},{"issue":"1","key":"33001_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong, P. et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint Blockade. Cell. Rep. 18 (1), 248\u2013262. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.019 (2017).","journal-title":"Cell. Rep."},{"issue":"7","key":"33001_CR26","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41584-022-00793-5","volume":"18","author":"N Komatsu","year":"2022","unstructured":"Komatsu, N. & Takayanagi, H. Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions. Nat. Rev. Rheumatol. 18 (7), 415\u2013429. https:\/\/doi.org\/10.1038\/s41584-022-00793-5 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"33001_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41413-022-00206-z","volume":"10","author":"Y Meirow","year":"2022","unstructured":"Meirow, Y. et al. Specific inflammatory osteoclast precursors induced during chronic inflammation give rise to highly active osteoclasts associated with inflammatory bone loss. Bone Res. 10 (1), 36. https:\/\/doi.org\/10.1038\/s41413-022-00206-z (2022).","journal-title":"Bone Res."},{"key":"33001_CR28","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fmed.2017.00234","volume":"4","author":"H Bi","year":"2017","unstructured":"Bi, H. et al. Key triggers of osteoclast-related diseases and available strategies for targeted therapies: A review. Front. Med. (Lausanne). 4, 234. https:\/\/doi.org\/10.3389\/fmed.2017.00234 (2017).","journal-title":"Front. Med. (Lausanne)"},{"issue":"6","key":"33001_CR29","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1136\/annrheumdis-2014-207137","volume":"75","author":"L Danks","year":"2016","unstructured":"Danks, L. et al. RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation. Ann. Rheum. Dis. 75 (6), 1187\u20131195. https:\/\/doi.org\/10.1136\/annrheumdis-2014-207137 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"33001_CR30","doi-asserted-by":"publisher","first-page":"601618","DOI":"10.3389\/fmed.2020.601618","volume":"7","author":"I Llorente","year":"2020","unstructured":"Llorente, I., Garc\u00eda-Casta\u00f1eda, N., Valero, C., Gonz\u00e1lez-\u00c1lvaro, I. & Casta\u00f1eda, S. Osteoporosis in rheumatoid arthritis: dangerous liaisons. Front. Med. (Lausanne). 7, 601618. https:\/\/doi.org\/10.3389\/fmed.2020.601618 (2020).","journal-title":"Front. Med. (Lausanne)"},{"key":"33001_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bone.2015.05.021","volume":"79","author":"N Levaot","year":"2015","unstructured":"Levaot, N. et al. Osteoclast fusion is initiated by a small subset of RANKL-stimulated monocyte progenitors, which can fuse to RANKL-unstimulated progenitors. Bone 79, 21\u201328. https:\/\/doi.org\/10.1016\/j.bone.2015.05.021 (2015).","journal-title":"Bone"},{"issue":"2","key":"33001_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.intimp.2014.12.012","volume":"24","author":"K Gan","year":"2015","unstructured":"Gan, K. et al. Celastrol attenuates bone erosion in collagen-Induced arthritis mice and inhibits osteoclast differentiation and function in RANKL-induced RAW264.7. Int. Immunopharmacol. 24 (2), 239\u2013246. https:\/\/doi.org\/10.1016\/j.intimp.2014.12.012 (2015).","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"33001_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.7326\/0003-4819-151-4-200908180-00005","volume":"151","author":"R Goldbach-Mansky","year":"2009","unstructured":"Goldbach-Mansky, R. et al. Comparison of tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial. Ann. Intern. Med. 151 (4), 229\u2013240. https:\/\/doi.org\/10.7326\/0003-4819-151-4-200908180-00005 (2009). W49-51.","journal-title":"Ann. Intern. Med."},{"key":"33001_CR34","doi-asserted-by":"publisher","first-page":"107879","DOI":"10.1016\/j.intimp.2021.107879","volume":"98","author":"M Jing","year":"2021","unstructured":"Jing, M. et al. Celastrol inhibits rheumatoid arthritis through the ROS-NF-\u03baB-NLRP3 inflammasome axis. Int. Immunopharmacol. 98, 107879. https:\/\/doi.org\/10.1016\/j.intimp.2021.107879 (2021).","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"33001_CR35","doi-asserted-by":"publisher","first-page":"R70","DOI":"10.1186\/ar2268","volume":"9","author":"L Tong","year":"2007","unstructured":"Tong, L. & Moudgil, K. D. Celastrus aculeatus Merr. Suppresses the induction and progression of autoimmune arthritis by modulating immune response to heat-shock protein 65. Arthritis Res. Ther. 9 (4), R70. https:\/\/doi.org\/10.1186\/ar2268 (2007).","journal-title":"Arthritis Res. Ther."},{"issue":"17","key":"33001_CR36","doi-asserted-by":"publisher","first-page":"15138","DOI":"10.1074\/jbc.M111.226365","volume":"286","author":"SH Venkatesha","year":"2011","unstructured":"Venkatesha, S. H., Yu, H., Rajaiah, R., Tong, L. & Moudgil, K. D. Celastrus-derived Celastrol suppresses autoimmune arthritis by modulating antigen-induced cellular and humoral effector responses. J. Biol. Chem. 286 (17), 15138\u201315146. https:\/\/doi.org\/10.1074\/jbc.M111.226365 (2011).","journal-title":"J. Biol. Chem."},{"key":"33001_CR37","doi-asserted-by":"publisher","unstructured":"Laraib, I., Qasim, S., Uttra, A. M. & Ahmed, S. R. Ocimene mitigates pyroptosis through TLR4\/NLRP3-mediated mechanisms in CFA-induced inflammation. Inflammopharmacol. Publ. Online Apr. 23 https:\/\/doi.org\/10.1007\/s10787-025-01756-4 (2025).","DOI":"10.1007\/s10787-025-01756-4"},{"issue":"1","key":"33001_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cytogfr.2008.11.007","volume":"20","author":"J Xu","year":"2009","unstructured":"Xu, J. et al. NF-kappaB modulators in osteolytic bone diseases. Cytokine Growth Factor. Rev. 20 (1), 7\u201317. https:\/\/doi.org\/10.1016\/j.cytogfr.2008.11.007 (2009).","journal-title":"Cytokine Growth Factor. Rev."},{"issue":"1","key":"33001_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00011-024-01983-5","volume":"74","author":"H Lei","year":"2025","unstructured":"Lei, H. et al. The role of Celastrol in inflammation and diseases. Inflamm. Res. 74 (1), 23. https:\/\/doi.org\/10.1007\/s00011-024-01983-5 (2025).","journal-title":"Inflamm. Res."},{"key":"33001_CR40","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu, T., Zhang, L., Joo, D. & Sun, S. C. NF-\u03baB signaling in inflammation. Signal. Transduct. Target. Ther. 2, 17023. https:\/\/doi.org\/10.1038\/sigtrans.2017.23 (2017).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"6","key":"33001_CR41","doi-asserted-by":"publisher","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence, T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb. Perspect. Biol. 1 (6), a001651. https:\/\/doi.org\/10.1101\/cshperspect.a001651 (2009).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"33001_CR42","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1146\/annurev.immunol.14.1.649","volume":"14","author":"AS Baldwin","year":"1996","unstructured":"Baldwin, A. S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649\u2013683. https:\/\/doi.org\/10.1146\/annurev.immunol.14.1.649 (1996).","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"33001_CR43","doi-asserted-by":"publisher","first-page":"a000034","DOI":"10.1101\/cshperspect.a000034","volume":"1","author":"A Oeckinghaus","year":"2009","unstructured":"Oeckinghaus, A. & Ghosh, S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol. 1 (4), a000034. https:\/\/doi.org\/10.1101\/cshperspect.a000034 (2009).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"2","key":"33001_CR44","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3390\/ijms23020905","volume":"23","author":"S Jang","year":"2022","unstructured":"Jang, S., Kwon, E. J. & Lee, J. J. Rheumatoid arthritis: pathogenic roles of diverse immune cells. Int. J. Mol. Sci. 23 (2), 905. https:\/\/doi.org\/10.3390\/ijms23020905 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"33001_CR45","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365 (23), 2205\u20132219. https:\/\/doi.org\/10.1056\/NEJMra1004965 (2011).","journal-title":"N. Engl. J. Med."},{"issue":"D1","key":"33001_CR46","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang, S. et al. Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res. 53 (D1), D1670\u2013D1676. https:\/\/doi.org\/10.1093\/nar\/gkae973 (2025).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33001-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33001-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33001-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:06:29Z","timestamp":1769220389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33001-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["33001"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-33001-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"29 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3137"}}